For the year ending 2025-12-31, PCSA has $7,813,567 in assets. $2,236,253 in debts. $5,536,955 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 5,536,955 | |||
| Prepaid expenses and other | 133,919 | |||
| Total current assets | 5,670,874 | |||
| Digital assets at fair value | 1,145,180 | |||
| Prepaid expenses | 993,701 | |||
| Equipment, net | 3,812 | |||
| Total assets | 7,813,567 | |||
| Accounts payable | 1,056,796 | |||
| Accrued expenses | 1,179,457 | |||
| Total current liabilities | 2,236,253 | |||
| Total liabilities | 2,236,253 | |||
| Common stock, par value 0.0001, 1,000,000,000 shares authorized 2,572,114 issued and 2,571,914 outstanding at december 31, 2025 and 148,308 issued and 148,108 outstanding at december 31, 2024 | 257 | |||
| Additional paid-in capital | 106,660,090 | |||
| Treasury stock, 200 shares at cost | 300,000 | |||
| Accumulated deficit | -100,783,033 | |||
| Total stockholders equity | 5,577,314 | |||
| Total liabilities and stockholders equity | 7,813,567 | |||
Processa Pharmaceuticals, Inc. (PCSA)
Processa Pharmaceuticals, Inc. (PCSA)